» Articles » PMID: 29228959

Micro-structural Bone Changes in Early Rheumatoid Arthritis Persist over 1-year despite Use of Disease Modifying Anti-rheumatic Drug Therapy

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2017 Dec 13
PMID 29228959
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We used High Resolution - peripheral Quantitative CT (HR-pQCT) imaging to examine peri-articular bone quality in early rheumatoid arthritis (RA) and explore whether bone quality improved over 12-months in individuals receiving care consistent with practice guidelines.

Methods: A 1-year longitudinal cohort study (Baseline and 12-months) evaluating individuals with early RA compared to age/sex-matched peers. Personal demographic and health and lifestyle information were collected for all. Whereas, active joint count (AJC), functional limitation, and RA medications were also collected for RA participants. HR-pQCT imaging analyses quantified bone density and microstructure in the Metacarpal Head (MH) and Ultra-Ultra-Distal (UUD) radius at baseline and 12-months. Analyses included a General Linear Modelling repeated measures analyses examined main effects for disease, time, and interaction on bone quality.

Results: Participants (n = 60, 30 RA/30 NRA); 80% female, mean age 53 (varying from 21 to 74 years). At baseline, RA participants were on average 7.7 months since diagnosis, presenting with few active joints (AJC: 30% none, remaining 70% Median 4 active joints) and minimal self-reported functional limitation (mHAQ-DI: 0.56). At baseline, 29 of 30 RA participants had received one or more non-biologic disease-modifying anti-rheumatic drugs (DMARD);13 in combination with glucocorticoid and 1 in combination with a biologic medication. One participant only received glucocorticoid medication. Four RA participants withdrew leaving 26 pairs (n = 52) at 12-months; 23 pairs (n = 46) with UUD and 22 pairs (n = 44) with MH baseline and 12-month images to compare. Notable RA/NRA differences (p < 0.05) in bone quality at all three sites included lower trabecular bone density and volume, more rod-like trabeculae, and larger and more variable spaces between trabeculae; fewer trabeculae at the UUD and MH2 sites; and lower cortical bone density and volume in the MH sites. Rate of change over 12-months did not differ between RA/NRA participants which meant there was also no improvement over the year in RA bone quality.

Conclusions: Early changes in peri-articular bone density and microstructure seen in RA are consistent with changes more commonly seen in aging bone and are slow or resistant to recover despite well controlled inflammatory joint symptoms with early DMARD therapy.

Citing Articles

Circulating Baseline CXCR3Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis.

Scheffler J, Drevinge C, Lindholm C, Gjertsson I, Lend K, Hetland M ACR Open Rheumatol. 2024; 7(1):e11742.

PMID: 39411912 PMC: 11667770. DOI: 10.1002/acr2.11742.


Image Registration in Longitudinal Bone Assessment Using Computed Tomography.

Liu H, Durongbhan P, Davey C, Stok K Curr Osteoporos Rep. 2023; 21(4):372-385.

PMID: 37264231 PMC: 10393902. DOI: 10.1007/s11914-023-00795-6.


Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats.

Lv D, Zhao X Arch Rheumatol. 2023; 38(1):22-31.

PMID: 37235123 PMC: 10208611. DOI: 10.46497/ArchRheumatol.2023.9240.


Bone erosion in the 2nd metacarpophalangeal head: association with its bone mineral density by HR-pQCT in rheumatoid arthritis patients.

Figueiredo C, Perez M, Sales L, Medeiros A, Caparbo V, Pereira R BMC Musculoskelet Disord. 2021; 22(1):109.

PMID: 33494725 PMC: 7836594. DOI: 10.1186/s12891-021-03992-5.


High-Resolution Peripheral Quantitative Computed Tomography for Bone Evaluation in Inflammatory Rheumatic Disease.

Klose-Jensen R, Tse J, Keller K, Barnabe C, Burghardt A, Finzel S Front Med (Lausanne). 2020; 7:337.

PMID: 32766262 PMC: 7381125. DOI: 10.3389/fmed.2020.00337.

References
1.
Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham 3rd C . 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69(9):1580-8. DOI: 10.1136/ard.2010.138461. View

2.
Innala L, Sjoberg C, Moller B, Ljung L, Smedby T, Sodergren A . Co-morbidity in patients with early rheumatoid arthritis - inflammation matters. Arthritis Res Ther. 2016; 18:33. PMC: 4730785. DOI: 10.1186/s13075-016-0928-y. View

3.
Kanis J, McCloskey E, Johansson H, Oden A, Leslie W . FRAX(®) with and without bone mineral density. Calcif Tissue Int. 2011; 90(1):1-13. DOI: 10.1007/s00223-011-9544-7. View

4.
Zhu T, Griffith J, Qin L, Hung V, Fong T, Au S . Alterations of bone density, microstructure, and strength of the distal radius in male patients with rheumatoid arthritis: a case-control study with HR-pQCT. J Bone Miner Res. 2014; 29(9):2118-29. DOI: 10.1002/jbmr.2221. View

5.
Kawalilak C, Johnston J, Olszynski W, Kontulainen S . Least significant changes and monitoring time intervals for high-resolution pQCT-derived bone outcomes in postmenopausal women. J Musculoskelet Neuronal Interact. 2015; 15(2):190-6. PMC: 5133723. View